Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-014747
Filing Date
2009-06-16
Accepted
2009-06-16 10:16:07
Documents
1
Period of Report
2009-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3429
  Complete submission text file 0001140361-09-014747.txt   5376
Mailing Address 135 WOOD STREET SUITE 205 WEST HAVEN CT 06516
Business Address 135 WOOD STREET SUITE 205 WEST HAVEN CT 06516 (203) 937-6137
NANOVIRICIDES, INC. (Issuer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 135 WOOD STREET SUITE 205 WEST HAVEN CT 06516
Business Address 135 WOOD STREET SUITE 205 WEST HAVEN CT 06516 203-937-6137
Theracour Pharma, Inc. (Reporting) CIK: 0001451613 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52318 | Film No.: 09893322